Dr. Rabeeya Khalid Sabzwari, MD

Dr. Sabzwari practices at Loyola Medicine Pediatric Mobile Health Unit in Maywood, Illinois.

Dr. Sabzwari's NPI, 1407050610, was assigned on June 12, 2007. Dr. Sabzwari holds Illinois license 036128212.

Dr. Sabzwari's primary practice is Loyola Medicine Pediatric Mobile Health Unit, at 2160 S 1st Avenue, Maywood, IL 60153. The practice phone is (708) 216-3299.

Dr. Sabzwari's primary practice is Loyola Medicine Pediatric Mobile Health Unit in Maywood, Illinois. Dr. Sabzwari is also affiliated with Loyola University Medical Center. The medical group on file is Loyola University Medical Center. Dr. Sabzwari's employer is on file too: a clinical lab.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sabzwari practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Sabzwari's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dmand AI has Dr. Sabzwari's licenses on file in 2 states: Illinois and Indiana.

CMS data shows 25 Medicare services from Dr. Sabzwari across 1 procedure code in 2024, all of them office visits, for 34 Medicare patients. Medicare paid $2,856 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 34 Medicare patients who saw Dr. Sabzwari in 2024. The largest group is 65 to 74, with 16 patients. 75% of them have copd, and 75% have high cholesterol. Their average risk score is 1.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sabzwari's median patient age at 74, with 48% women.

In 2024, Dr. Sabzwari wrote 226 Medicare Part D claims for 24 patients. 65% of them were for generic drugs. CMS names the drug for 194 of them, across 5 drugs with 11 or more claims each, at $884,382 in total drug cost. In 2023, CMS named 128 claims across 5 drugs.

Dr. Sabzwari accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 8 papers to Dr. Sabzwari, published from 2016 to 2025. 2016 was the busiest year, with 2. The most frequent topics are Mpox, Monkeypox, Spinal Cord Injuries and Veterans. Dr. Sabzwari has published most often in Fed Pract. Dr. Sabzwari's most frequent co-authors are Stephanie R. Black, MD, David Blythe and Stephen Burns, MD.

CMS Open Payments shows 1 general payment to Dr. Sabzwari from 1 drug or device company in 2023. Food and beverage make up the largest share, 100% of the total. Abbott Laboratories paid the most, $29.